LON:CRX - Cyprotex Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeGBX 84 - GBX 160.50
VolumeN/A
Average Volume22,515 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cyprotex PLC is a holding company. The Company and its subsidiaries are engaged in the provision of in vitro and in silico Absorption, Distribution, Metabolism, Excretion, Toxicity (ADMET) and Pharmacokinetic (PK) information to the pharmaceutical and biotechnology industries. It offers a range of different services in the areas of ADME-PK, in vitro toxicology, biosciences, in silico prediction, in vitro skin and ocular testing, endocrine disruption and physicochemical profiling. Its in vitro ADME and drug metabolism and pharmacokinetics (DMPK) services include in vitro metabolism, in vitro permeability and transporters, solubility and physicochemical properties, in vitro protein binding and PK and bioanalysis. It operates mainly in North America, Mainland Europe and the United Kingdom. It serves pharmaceutical, biotech, cosmetics, personal care, household products, chemical, agrochemical and tobacco markets. Its subsidiaries include Cyprotex Discovery Limited and Cyprotex US, LLC.

Receive CRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
Phone+44-1625-505100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Cyprotex (LON:CRX) Frequently Asked Questions

What is Cyprotex's stock symbol?

Cyprotex trades on the London Stock Exchange (LON) under the ticker symbol "CRX."

Has Cyprotex been receiving favorable news coverage?

News stories about CRX stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cyprotex earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term.

How do I buy shares of Cyprotex?

Shares of CRX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Cyprotex's official website?

The official website for Cyprotex is http://www.cyprotex.com/.

How can I contact Cyprotex?

Cyprotex's mailing address is 24, Mereside, Alderley Park, MACCLESFIELD, SK10 4TG, United Kingdom. The company can be reached via phone at +44-1625-505100.


MarketBeat Community Rating for Cyprotex (LON CRX)

Community Ranking:  1.1 out of 5 (star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  181
MarketBeat's community ratings are surveys of what our community members think about Cyprotex and other stocks. Vote "Outperform" if you believe CRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Featured Article: Quiet Period Expirations

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel